Serrapeptase
Also called: serratiopeptidase, serratia peptidase
A protein-digesting (proteolytic) enzyme derived from bacteria of the genus Serratia. A 2013 systematic review describes it as prescribed in several medical specialties for anti-inflammatory and pain-relief purposes and promoted as a health supplement.
- Category
- Other
- Forms
- Serratiopeptidase enzyme (from Serratia bacteria)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. A 2018 meta-analysis of randomized controlled studies included five studies of serratiopeptidase after impacted molar surgery; a 2013 systematic review found 24 clinical studies and judged their methodology poor. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMouth and teeth1 topic
CImmune system and infection1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Trismus, swelling and pain after impacted molar surgery | C | A 2018 meta-analysis (5 studies) found serratiopeptidase improved trismus more than corticosteroids (mean difference 4.42) with no difference in swelling; too few studies allowed conclusions on other outcomes or comparators. [2] |
| Anti-inflammatory and pain-relief use overall | C | A 2013 systematic review (24 clinical studies) found the evidence rests on studies of poor methodology, with only a few small, usually placebo-controlled RCTs, and judged it insufficient to support use as an analgesic or health supplement. [1] |
Main constituents: Serratiopeptidase, a proteolytic enzyme [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications3 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- A 2013 systematic review found data on the safety and tolerability of serratiopeptidase lacking in the published studies, and no data on long-term safety. [1]
- MSK (nattokinase monograph) case report: vascular necrosis leading to arm amputation in a 47-year-old man who injected an oral enzyme supplement containing serrapeptase and nattokinase into a blood vessel. [3]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [4]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Serratiopeptidase Enzyme (protease from Serratia bacteria) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 3 entries naming serratiopeptidase or a peptidase enzyme from Serratia bacteria (earliest NDI 6 submitted 1996-05-17; most recent NDI 1236 submitted 2021-11-24). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of serrapeptase (serratiopeptidase) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-30). [P2]
- The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of serrapeptase (serratiopeptidase) (checked 2026-10-30). [P3]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg 2013;11(3):209-17 (PMID 23380245), 2013. pubmed.ncbi.nlm.nih.gov
Sources
- Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg 2013;11(3):209-17 (PMID 23380245), 2013. pubmed.ncbi.nlm.nih.gov
- Sivaramakrishnan G, Sridharan K. Role of serratiopeptidase after surgical removal of impacted molar: a systematic review and meta-analysis. J Maxillofac Oral Surg 2018;17(2):122-128 (PMID 29618875), 2018-06. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Nattokinase (last updated Thursday, April 14, 2022), 2022-04-14. mskcc.org
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.